Cardiac implantable electronic device surgery with interruption of warfarin forgoing post-operative bridging therapy in patients with moderate or high thromboembolic risks

BACKGROUND: For patients taking warfarin and undergoing pacemaker or implantable cardioverter-defibrillator surgery, clinical evidence and guidelines support continuation of warfarin therapy, as opposed to interruption of warfarin therapy with heparin bridging. Interruption of warfarin without post-...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Andrew Kei-Yan, Ng, Pauline Yeung, Tam, Eva Wai-Ying, Siu, Chung-Wah, Fan, Katherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082611/
https://www.ncbi.nlm.nih.gov/pubmed/33926467
http://dx.doi.org/10.1186/s12959-021-00279-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082611/
https://www.ncbi.nlm.nih.gov/pubmed/33926467
http://dx.doi.org/10.1186/s12959-021-00279-6

Ejemplares similares